Publications by authors named "Andrew R Green"

100Publications

The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer.

Breast Cancer Res Treat 2020 Oct 19. Epub 2020 Oct 19.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, NG7 2RD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-020-05955-1DOI Listing
October 2020

Correction: The clinical significance of oestrogen receptor expression in breast ductal carcinoma in situ.

Br J Cancer 2020 Sep 16. Epub 2020 Sep 16.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, The University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-020-01097-9DOI Listing
September 2020

Werner Syndrome Protein Expression in Breast Cancer.

Clin Breast Cancer 2020 Jul 25. Epub 2020 Jul 25.

Department of Oncology, Nottingham University Hospitals, Nottingham, UK; Translational Oncology, Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2020.07.013DOI Listing
July 2020

The nucleolar-related protein Dyskerin pseudouridine synthase 1 (DKC1) predicts poor prognosis in breast cancer.

Br J Cancer 2020 Sep 1. Epub 2020 Sep 1.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-020-01045-7DOI Listing
September 2020

The clinical significance of oestrogen receptor expression in breast ductal carcinoma in situ.

Br J Cancer 2020 Aug 10. Epub 2020 Aug 10.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, The University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-020-1023-3DOI Listing
August 2020

Molecular Complexity of Lymphovascular Invasion: The Role of Cell Migration in Breast Cancer as a Prototype.

Pathobiology 2020 9;87(4):218-231. Epub 2020 Jul 9.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham, United Kingdom,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000508337DOI Listing
July 2020

Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy.

Front Cell Dev Biol 2020 3;8:402. Epub 2020 Jun 3.

Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fcell.2020.00402DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283917PMC
June 2020

Integrated Analysis of Key Differentially Expressed Genes Identifies DBN1 as a Predictive Marker of Response to Endocrine Therapy in Luminal Breast Cancer.

Cancers (Basel) 2020 Jun 12;12(6). Epub 2020 Jun 12.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham NG7 2RD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12061549DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352383PMC
June 2020

Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival.

Breast Cancer Res Treat 2020 Jul 22;182(2):267-282. Epub 2020 May 22.

Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-020-05670-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297818PMC
July 2020

PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer.

BMC Cancer 2020 May 14;20(1):425. Epub 2020 May 14.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, NG7 2RD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-020-06939-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227113PMC
May 2020

The prognostic significance of ALDH1A1 expression in early invasive breast cancer.

Histopathology 2020 Sep 4;77(3):437-448. Epub 2020 Sep 4.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.14129DOI Listing
September 2020

Retrospective assessment of cyclin-dependent kinase 5 mRNA and protein expression and its association with patient survival in breast cancer.

J Cell Mol Med 2020 Jun 30;24(11):6263-6271. Epub 2020 Apr 30.

Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham Biodiscovery Institute, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jcmm.15268DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294162PMC
June 2020

Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer.

Breast Cancer Res Treat 2020 Jun 29;181(3):541-551. Epub 2020 Apr 29.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, NG7 2RD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-020-05646-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220876PMC
June 2020

SPAG5: An Emerging Oncogene.

Trends Cancer 2020 07 11;6(7):543-547. Epub 2020 Apr 11.

The Centre for Biomedical and Chemical Sciences, School of Science, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trecan.2020.03.006DOI Listing
July 2020

The prognostic significance of immune microenvironment in breast ductal carcinoma in situ.

Br J Cancer 2020 May 17;122(10):1496-1506. Epub 2020 Mar 17.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-020-0797-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217899PMC
May 2020

The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer.

Breast Cancer Res Treat 2020 May 21;181(1):1-12. Epub 2020 Mar 21.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, NG7 2RD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-020-05586-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182634PMC
May 2020

Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer.

Int J Mol Sci 2020 Feb 19;21(4). Epub 2020 Feb 19.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham NG7 2RD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms21041407DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073058PMC
February 2020

Enhanced glutamine uptake influences composition of immune cell infiltrates in breast cancer.

Br J Cancer 2020 01 10;122(1):94-101. Epub 2019 Dec 10.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-019-0626-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964696PMC
January 2020

Dopamine and cAMP-regulated phosphoprotein 32 kDa (DARPP-32) and survival in breast cancer: a retrospective analysis of protein and mRNA expression.

Sci Rep 2019 11 18;9(1):16987. Epub 2019 Nov 18.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-53529-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861271PMC
November 2019

Prognostic significance of nucleolar assessment in invasive breast cancer.

Histopathology 2020 Apr 26;76(5):671-684. Epub 2020 Mar 26.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.14036DOI Listing
April 2020

Clinicopathological significance of lipocalin 2 nuclear expression in invasive breast cancer.

Breast Cancer Res Treat 2020 Feb 9;179(3):557-564. Epub 2019 Nov 9.

Division of Cancer and Stem Cells, School of Medicine, Nottingham Breast Cancer Research Centre, University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05488-2DOI Listing
February 2020

Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer.

Breast Cancer Res Treat 2020 Jan 2;179(2):349-357. Epub 2019 Nov 2.

Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, The University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05466-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987050PMC
January 2020

The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer.

Breast Cancer Res Treat 2020 Jan 10;179(1):79-90. Epub 2019 Oct 10.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05459-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985218PMC
January 2020

The role of glutaminase in cancer.

Histopathology 2020 Mar 18;76(4):498-508. Epub 2020 Feb 18.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.14014DOI Listing
March 2020

Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer.

Br J Cancer 2019 10 27;121(9):776-785. Epub 2019 Sep 27.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-019-0589-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889395PMC
October 2019

The intra-tumoural stroma in patients with breast cancer increases with age.

Breast Cancer Res Treat 2020 Jan 18;179(1):37-45. Epub 2019 Sep 18.

Department of Surgery, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05422-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985058PMC
January 2020

Activated zinc transporter ZIP7 as an indicator of anti-hormone resistance in breast cancer.

Metallomics 2019 09 4;11(9):1579-1592. Epub 2019 Sep 4.

Breast Cancer Molecular Pharmacology Unit, School of Pharmacy and Pharmaceutical Sciences, Redwood Building, Cardiff University, King Edward VII Avenue, Cardiff, CF10 3NB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c9mt00136kDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796783PMC
September 2019

CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy.

Breast Cancer Res Treat 2019 Dec 30;178(3):535-544. Epub 2019 Aug 30.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05420-8DOI Listing
December 2019

Surgical management of ductal carcinoma in situ of the breast: A large retrospective study from a single institution.

Breast J 2019 11 18;25(6):1143-1153. Epub 2019 Jul 18.

Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, Nottingham City Hospital, The University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.13425DOI Listing
November 2019

Combining clustering and classification ensembles: A novel pipeline to identify breast cancer profiles.

Artif Intell Med 2019 06 15;97:27-37. Epub 2019 May 15.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Nottingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.artmed.2019.05.002DOI Listing
June 2019

Collagen (XI) alpha-1 chain is an independent prognostic factor in breast ductal carcinoma in situ.

Mod Pathol 2019 10 7;32(10):1460-1472. Epub 2019 Jun 7.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-019-0286-9DOI Listing
October 2019

Geometric characteristics of collagen have independent prognostic significance in breast ductal carcinoma in situ: an image analysis study.

Mod Pathol 2019 10 7;32(10):1473-1485. Epub 2019 Jun 7.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-019-0296-7DOI Listing
October 2019

Investigation of the Amide Proton Solvent Exchange Properties of Glycosaminoglycan Oligosaccharides.

J Phys Chem B 2019 06 22;123(22):4653-4662. Epub 2019 May 22.

Department of Chemistry , University of California-Riverside , Riverside , California 92501 , United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jpcb.9b01794DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732216PMC
June 2019

The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution.

Br J Cancer 2019 05 8;120(11):1075-1082. Epub 2019 May 8.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, The University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41416-019-0436-3
Publisher Site
http://dx.doi.org/10.1038/s41416-019-0436-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738110PMC
May 2019

H NMR characterization of chitin tetrasaccharide in binary HO:DMSO solution: Evidence for anomeric end-effect propagation.

Int J Biol Macromol 2019 May 13;129:744-749. Epub 2019 Feb 13.

Department of Chemistry, University of California - Riverside, Riverside, CA 92521, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijbiomac.2019.02.062DOI Listing
May 2019

The molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: high throughput analysis of large cohorts.

Mod Pathol 2019 07 13;32(7):967-976. Epub 2019 Feb 13.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-019-0209-9DOI Listing
July 2019

The prognostic significance of lysosomal protective protein (cathepsin A) in breast ductal carcinoma in situ.

Histopathology 2019 Jun 14;74(7):1025-1035. Epub 2019 Apr 14.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham City Hospital, Notts, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13835DOI Listing
June 2019

Liver Kinase B1-A Potential Therapeutic Target in Hormone-Sensitive Breast Cancer in Older Women.

Cancers (Basel) 2019 Jan 28;11(2). Epub 2019 Jan 28.

Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, DE22 3DT Nottingham, United Kingdom.

View Article

Download full-text PDF

Source
http://www.mdpi.com/2072-6694/11/2/149
Publisher Site
http://dx.doi.org/10.3390/cancers11020149DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406422PMC
January 2019

The combined expression of solute carriers is associated with a poor prognosis in highly proliferative ER+ breast cancer.

Breast Cancer Res Treat 2019 May 22;175(1):27-38. Epub 2019 Jan 22.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-05111-wDOI Listing
May 2019

Expression of Lamin A/C in early-stage breast cancer and its prognostic value.

Breast Cancer Res Treat 2019 Apr 4;174(3):661-668. Epub 2019 Jan 4.

Division of Breast Surgery, The University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-05092-wDOI Listing
April 2019

Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer.

Breast Cancer Res Treat 2019 Apr 15;174(2):387-399. Epub 2018 Dec 15.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-05085-9DOI Listing
April 2019

Connexin 43 is an independent predictor of patient outcome in breast cancer patients.

Breast Cancer Res Treat 2019 Feb 24;174(1):93-102. Epub 2018 Nov 24.

Cancer Immunology Group, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-018-5063-9
Publisher Site
http://dx.doi.org/10.1007/s10549-018-5063-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418069PMC
February 2019

Glutamate dehydrogenase (GLUD1) expression in breast cancer.

Breast Cancer Res Treat 2019 Feb 23;174(1):79-91. Epub 2018 Nov 23.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-5060-zDOI Listing
February 2019

Legumain is an independent predictor for invasive recurrence in breast ductal carcinoma in situ.

Mod Pathol 2019 05 14;32(5):639-649. Epub 2018 Nov 14.

Department of Histopathology, Nottingham Breast Cancer Research Center, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham University Hospital NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-018-0180-xDOI Listing
May 2019

Prolyl-4-hydroxylase Α subunit 2 (P4HA2) expression is a predictor of poor outcome in breast ductal carcinoma in situ (DCIS).

Br J Cancer 2018 12 9;119(12):1518-1526. Epub 2018 Nov 9.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0337-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288166PMC
December 2018

Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.

Breast Cancer Res Treat 2019 Jan 10;173(1):93-102. Epub 2018 Oct 10.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-018-4978-5
Publisher Site
http://dx.doi.org/10.1007/s10549-018-4978-5DOI Listing
January 2019

Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma Induces Synthetic Lethality and Chemoprevention.

Cancer Res 2018 12 8;78(24):6818-6827. Epub 2018 Oct 8.

Translational Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham, United Kingdom.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-54
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-18-0633DOI Listing
December 2018

Impact of breast cancer grade discordance on prediction of outcome.

Histopathology 2018 Dec 19;73(6):904-915. Epub 2018 Sep 19.

Department of Histopathology, South Austin Hospital, Austin, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13709DOI Listing
December 2018

Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion.

Mod Pathol 2018 11 28;31(11):1675-1682. Epub 2018 Jun 28.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-018-0092-9DOI Listing
November 2018

Thioredoxin-interacting protein is an independent risk stratifier for breast ductal carcinoma in situ.

Mod Pathol 2018 12 28;31(12):1807-1815. Epub 2018 Jun 28.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-018-0086-7DOI Listing
December 2018

Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance.

Histopathology 2018 Dec 9;73(6):887-896. Epub 2018 Oct 9.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13695DOI Listing
December 2018

Low expression of G protein-coupled oestrogen receptor 1 (GPER) is associated with adverse survival of breast cancer patients.

Oncotarget 2018 May 25;9(40):25946-25956. Epub 2018 May 25.

Translational and Radiation Biology Research Group, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25408DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995224PMC
May 2018

Current issues with luminal subtype classification in terms of prediction of benefit from endocrine therapy in early breast cancer.

Histopathology 2018 Oct 28;73(4):545-558. Epub 2018 May 28.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13523DOI Listing
October 2018

Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.

Br J Cancer 2018 04 28;118(8):1142-1151. Epub 2018 Mar 28.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0041-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931067PMC
April 2018

The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours.

Breast Cancer Res 2018 03 22;20(1):21. Epub 2018 Mar 22.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-018-0946-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863851PMC
March 2018

Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast.

Mod Pathol 2018 08 20;31(8):1226-1236. Epub 2018 Mar 20.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-018-0040-8DOI Listing
August 2018

The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes.

Br J Cancer 2018 04 16;118(8):1115-1122. Epub 2018 Mar 16.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0038-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931111PMC
April 2018

Breast cancer histologic grading using digital microscopy: concordance and outcome association.

J Clin Pathol 2018 Aug 13;71(8):680-686. Epub 2018 Mar 13.

Department of Histopathology, South Austin Hospital, Austin, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2017-204979DOI Listing
August 2018

Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy.

Breast Cancer Res Treat 2018 Jun 2;169(2):277-286. Epub 2018 Feb 2.

Translational Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4683-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945733PMC
June 2018

High nuclear MSK1 is associated with longer survival in breast cancer patients.

J Cancer Res Clin Oncol 2018 Mar 11;144(3):509-517. Epub 2018 Jan 11.

University of Nottingham, Division of Cancer and Stem Cells, Department of Clinical Oncology, School of Medicine, Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-018-2579-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816103PMC
March 2018

IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients.

Cancer Immunol Immunother 2018 Apr 18;67(4):537-549. Epub 2017 Dec 18.

Division of Cancer and Stem Cells, Academic Clinical Oncology, School of Medicine, University of Nottingham, Nottingham University Hospitals NHS Trust, City Hospital Campus, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-017-2106-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860102PMC
April 2018

MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer.

Br J Cancer 2018 01 23;118(2):258-265. Epub 2017 Nov 23.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1038/bjc.2017.387
Publisher Site
http://dx.doi.org/10.1038/bjc.2017.387DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785743PMC
January 2018

Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations.

Histopathology 2018 Jan 17;72(2):183-190. Epub 2017 Oct 17.

Academic Pathology, University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13334DOI Listing
January 2018

Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections.

Breast Cancer Res Treat 2017 Jul 6;164(2):341-348. Epub 2017 May 6.

Department of Histopathology, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4270-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487701PMC
July 2017

Phenotypic characterisation of breast cancer: the role of CDC42.

Breast Cancer Res Treat 2017 Jul 27;164(2):317-325. Epub 2017 Apr 27.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4267-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487723PMC
July 2017

Chemokine (C-C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinoma.

J Pathol Clin Res 2017 Apr 30;3(2):105-114. Epub 2017 Mar 30.

Division of Cancer and Stem Cells, School of MedicineThe University of Nottingham, and Nottingham City Hospital, Nottingham University Hospitals NHS TrustNottinghamUK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cjp2.65DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402178PMC
April 2017

Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ.

Histopathology 2017 Aug 26;71(2):258-268. Epub 2017 May 26.

Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13217DOI Listing
August 2017